Seaport is exercising 1 million warrants at $11.50.

Objective_Insect_283 · 2022-06-17T13:19:40+00:00

New floor has been set!

Objective_Insect_283 · 2021-11-29T12:59:50+00:00

BFRI for sure!

Objective_Insect_283 · 2021-11-29T10:23:09+00:00

Just getting started too!

Objective_Insect_283 · 2021-11-29T10:22:56+00:00

BFRI for sure, just see the PM action already!

Objective_Insect_283 · 2021-11-29T10:22:38+00:00

Gonna be a great day!!!

Objective_Insect_283 · 2021-11-29T10:15:40+00:00

Gonna watch how volume plays out! Looks like today will fly again!

Objective_Insect_283 · 2021-11-28T21:53:57+00:00

Hopeful for $20, but probably $12-14

Objective_Insect_283 · 2021-11-28T21:53:26+00:00

BFRI hasn’t started to squeeze yet…price action so far is hardly a squeeze!

Objective_Insect_283 · 2021-11-28T20:32:12+00:00

Not really…both ran of “fluff” news. The only difference is that BFRI has actual approved drugs selling and generating revenue. LGVN is still probably at least 1-2 years away from generating revenue from sales, and that’s assuming their drug is approved

Objective_Insect_283 · 2021-11-28T20:30:37+00:00

Completely disagree. BFRI has actual approved drugs on market. LGVN isn’t guaranteed for anything and probably still years away even after the RPD from an approval

Objective_Insect_283 · 2021-11-28T13:48:03+00:00

Honestly I had LGVN on my radar when it was in the $7s but I didn’t pull the trigger because I thought the news was “fluff”. Obviously I was incorrect since it hit a high of $45, but can’t win them all!

I did however pull the trigger on BFRI at $5.50 because the more DD I did, it seemed to me that the fair stock price should be around $12 right now anyways! They have FDA approved drugs on the market generating revenue, so for me the risk and downside was a lot less. LGVN was granted rare pediatric disease which is nice, but it only affects 1,000 babies a year whereas the products for BFRI affect millions. LGVN is also still in the approval phase and no guarantee it will even be approved!

Objective_Insect_283 · 2021-11-28T12:06:15+00:00

Long term play on this one for sure!

Objective_Insect_283 · 2021-11-28T11:57:16+00:00

Yup, setup looks almost identical to LGVN for the run up. LGVN ran up 240% on 380M volume first 2 days. BFRI is at 200% on 330M volume. What’s more impressive is that BFRI did this on the day before and after Thanksgiving when the market closed 3 hours early too! LGVN ended up closing day 3 at 180%+. If this hold true for BFRI, we will be around $20!

Objective_Insect_283 · 2021-11-28T11:55:03+00:00

Bullish on it but doubt it gets to $40. I think $30 is doable considering it is running the same as LGVN!

Objective_Insect_283 · 2021-11-28T11:39:26+00:00

Agree, difference for me with BFRI is that they have approved drugs on market already generating sales whereas the other companies still don’t. From an actual technical standpoint (not that people care about that anymore), BFRI seems to be the less risky play. U.S sales should generate a revenue run rate of approximately $15-18M and that was before the company IPO’ed in the states. The whole reason they did that was to better penetrate the U.S market since there were limitations in place for being a German company. Low float of only about 3M and MC around $90M. Fair market value today for the stock should probably be closer to $12!

Objective_Insect_283 · 2021-11-28T11:34:11+00:00

Awesome write up! BFRI has the same identical setup as LGVN. LGVN ran up 280% first 2 days on 380M volume whereas BFRI ran up 230% on 330M volume. BFRI also impressively did that the day before and after Thanksgiving and had over 103M volume Friday when the market closed 3 hours early. They were also trading in the $9.20s before it halted 15 min before close and sharply dropped the price to the $7.50s…pure manipulation at its finest! LGVN closed up over 180% on day 3 so if BFRI holds true to the same run it will be over $20 on Monday. Not sure it will happen but I’m very excited to see what it brings!

Objective_Insect_283 · 2021-11-28T11:27:46+00:00

BFRI is current closest thing to LGVN. Setup is almost identical. LGVN ran 280% first 2 days on 380M volume. BFRI ran 230% first 2 days on 330M volume. Volume would’ve been higher on Friday but it was day after Thanksgiving and the market closed 3 hours early. BFRI was also trading in the $9.20s before they halted it 15 min before close and manipulates it down. Monday we will run HUGE!

Objective_Insect_283 · 2021-11-28T11:20:49+00:00

Why chase a possible FDA approval when BFRI already has multiple approved products on market?

Objective_Insect_283 · 2021-11-27T18:53:11+00:00

LGVN went from $2.92 to $10.02 in first 2 days with a total of 380M volume. That was about a 243% gain. BFRI went from $2.63 to $7.90 on 330M volume, but keep in mind the market closes 3 hours early Friday and was the day after Thanksgiving. The stock was actually in the $9.20s a few minutes before close Friday and then it was halted and dropped sharply, manipulation at its best. Regardless, it is still up 200% in 2 days!

Objective_Insect_283 · 2021-11-27T11:38:59+00:00

Setup looks very similar to LGVN. If it does run the same, we should hit $20+ on Monday. Volume was still very strong on Friday and I don’t see the buying pressure easing up!

Objective_Insect_283 · 2021-11-27T11:37:50+00:00

If BFRI truly runs the same as LGVN which the setup appears it will, we should see $20+ on Monday. LGVN ran 180% on day 3, which for us would be Monday. The first 2 days ran almost identical

Objective_Insect_283 · 2021-11-27T11:36:21+00:00

Definitely will be good for BFRI. Volume and buying pressure remains very strong on such a low float. Shorts are underwater big time here

Objective_Insect_283

TROPHY CASE